Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study June 2025 Congress News Read more
2023 May Clinical trials Gut microbiome associated with clinical responses to CAR-T immunotherapy in lymphoma patients Read more
2023 April Clinical trials Efficacy and safety of fitusiran prophylaxis in patients with haemophilia Read more
2023 April General Rondaptivon pegol can be used as a treatment for severe and nonsevere haemophilia A Read more
2023 March Clinical trials Efficacy and safety of emicizumab demonstrated in people with mild or moderate haemophilia A Read more
2023 February Medical Research Mitochondrial fusion as a new therapeutic target in acute myeloid leukaemia Read more
Top
